PsychedelicNewsWire

All the fast-moving companies, hot news and info about breakthroughs in psychedelic therapeutics and mushrooms as medicine. Full disclaimers:

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $OPTH $OPTI.CN $8BN.F Featured in Diamond Equity Research Initiation Report Highlighting Commercial Psychedelics Opportunity https://t.co/hqIzRVo5rU #stocks #stockmarket #psychedelics

[PsychedelicNewsWire @PsychedelicWire]

$NRXP advancing ketamine therapies as momentum builds around psychedelic decriminalization #stocks #psychadelic #decriminalization

[PsychedelicNewsWire @PsychedelicWire]

BioMedNewsBreaks — $NRXP Receives FDA Clearance for Depression and Suicidality Trial https://t.co/rwMuCXSKAM #stocks #biomedical #FDA #depression

[PsychedelicNewsWire @PsychedelicWire]

NetworkNewsBreaks – $NRXP Initiates First Commercial Manufacturing Order For Preservative-Free Ketamine https://t.co/M1ZvPrnAlA #stocks #NRXP #ketamine #commercialmanufacturing

[PsychedelicNewsWire @PsychedelicWire]

BioMedNewsBreaks — $NRXP Receives Positive FDA Review Letter Supporting Ketamine ANDA Progress https://t.co/iqWAi2pJ4g #stocks #biotech #FDA #ketamine #NRXP

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $OPTI.CN $OPTHF $8BN.F Launches Ibogaine Initiative Amid U.S. Policy Shift https://t.co/6tjbuS7wTR #stocks #stockmarket #psychedelics #biopharmaceutical #investment #OPTI

[PsychedelicNewsWire @PsychedelicWire]

DefenseNewsBreaks – $NRXP Forms NRx Defense Systems Subsidiary to Advance Neuroplastic Therapies for Military and Government Applications https://t.co/RhbQHiDjkR #stocks #defensenews #militaryhealth #neuroplastictherapies #govinnovation

[PsychedelicNewsWire @PsychedelicWire]

MissionIRNewsBreaks – $NRXP Appoints First Chief Commercial Officer Ahead of Ketamine Launch https://t.co/LhGts7gkxl #stocks #stockmarket #finance #NRXP #ketamine

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $NRXP Receives FDA Labeling Feedback for Preservative-Free Ketamine Application https://t.co/pUWNnMm2hs

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $NRXP Positioning at the Forefront of Next-Gen Treatment https://t.co/PD2sJlKePh

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $NRXP Eliminates Balance Sheet Debt Through Anson Equity Conversion https://t.co/TCsKOb9Qp5

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $NRXP Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical https://t.co/RJ1bjl7Ds0

[PsychedelicNewsWire @PsychedelicWire]

$NRXP Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies https://t.co/SZmhjMJv3d

[PsychedelicNewsWire @PsychedelicWire]

$NRXP Appoints TMS, Neuroplasticity Researcher Joshua Brown MD, PhD, as Chief Medical Innovation Officer https://t.co/vra9gqH59H

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $NRXP Appoints Prof. Joshua C. Brown As Chief Medical Innovation Officer https://t.co/OzK1wp6Toi

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $NRXP Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 https://t.co/FAkth5L0zc

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $NRXP Eliminates Balance Sheet Debt Through Anson Equity Conversion https://t.co/TCsKOb9Qp5

[PsychedelicNewsWire @PsychedelicWire]

PsychedelicNewsBreaks – $NRXP to Present at NobleCon21 https://t.co/26eDWhM38q

[PsychedelicNewsWire @PsychedelicWire]

$NRXP Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies https://t.co/SZmhjMJv3d

[PsychedelicNewsWire @PsychedelicWire]

MissionIRNewsBreaks – $NRXP Advances KETAFREE(TM), Expands Pipeline Targeting Urgent Needs https://t.co/grcIkJ5huO